Literature DB >> 27364378

Quantification of EtG in hair, EtG and EtS in urine and PEth species in capillary dried blood spots to assess the alcohol consumption in driver's licence regranting cases.

Natalie Kummer1, Sarah M R Wille1, Anneleen Poll2, Willy E E Lambert3, Nele Samyn1, Christophe P Stove4.   

Abstract

BACKGROUND: In Belgium, the analysis of indirect biomarkers such as carbohydrate deficient transferrin (CDT%), gamma-glutamyltransferase (GGT), aspartate aminotransferase/alanine aminotransferase (AST/ALT) and mean corpuscular volume (MCV), is currently used to monitor the alcohol consumption in cases of fitness to drive assessment. We evaluated the use of direct ethanol markers for this purpose, exclusively determined in matrices obtained via non- or minimally invasive sampling.
METHODS: Three validated quantitative methods (ethylglucuronide (EtG) in hair and urine, ethylsulfate (EtS) in urine, and phosphatidylethanol species (PEth 16:0/18:1, PEth 18:1/18:1 and PEth 16:0/16:0) in capillary dried blood spots (C-DBS)) were used. Fifty volunteers, for whom fitness to drive had to be assessed and for whom a blood analysis for indirect biomarkers was requested, were included in the study. The sampling and analysis of hair, urine and C-DBS were added to the process currently used.
RESULTS: Hair EtG (24/50) and C-DBS PEths (29/50) are more sensitive than the currently used indirect biomarkers (13/50 for CDT%) to detect excessive and chronic alcohol consumption and allow to disprove an abstinence period. Urinary EtG and EtS are useful parameters to determine recent alcohol consumption.
CONCLUSION: The combined use of the three strategies allows better inference about the evolution of the alcohol consumption prior to the sampling. Moreover, the exclusive use of non- or minimally invasive sampling (hair, urine and C-DBS) allows this to be performed directly during the fitness to drive assessment by regular staff members. This approach offers the potential to improve the Belgian driver's licence regranting process.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Abstinence period; Alcohol monitoring; Dependence; Direct biomarkers; Driver's licence; Fitness to drive

Mesh:

Substances:

Year:  2016        PMID: 27364378     DOI: 10.1016/j.drugalcdep.2016.06.012

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  5 in total

1.  Phosphatidylethanol in Comparison to Self-Reported Alcohol Consumption Among HIV-Infected Women in a Randomized Controlled Trial of Naltrexone for Reducing Hazardous Drinking.

Authors:  Yan Wang; Xinguang Chen; Judith A Hahn; Babette Brumback; Zhi Zhou; Maria J Miguez; Robert L Cook
Journal:  Alcohol Clin Exp Res       Date:  2017-12-05       Impact factor: 3.455

2.  Phosphatidylethanol Levels Among Incarcerated Women: The Influence of Pre-incarceration Alcohol Consumption and Length of Abstinence.

Authors:  Kelly E Moore; Olga J Santiago Rivera; Bradley Anderson; Jennifer E Johnson; Judith A Hahn; Megan E Kurth; Madhavi K Reddy; Yael C Schonbrun; Michael D Stein
Journal:  Alcohol Clin Exp Res       Date:  2018-01-31       Impact factor: 3.455

3.  The Formation, Elimination, Interpretation, and Future Research Needs of Phosphatidylethanol for Research Studies and Clinical Practice.

Authors:  Judith A Hahn; Raymond F Anton; Martin A Javors
Journal:  Alcohol Clin Exp Res       Date:  2016-09-26       Impact factor: 3.455

4.  Comments on "Evaluation and review of ways to differentiate sources of ethanol in post-mortem blood".

Authors:  Florian Hakim; Thomas Gicquel; Delphine Allorge; Jean-Michel Gaulier
Journal:  Int J Legal Med       Date:  2021-02-20       Impact factor: 2.686

5.  Internal and External Validation of an Alcohol Biomarker for Screening in Trauma.

Authors:  Majid Afshar; Kenneth Baker; Josefine Corral; Erin Ross; Erin Lowery; Richard Gonzalez; Ellen L Burnham; Rachael A Callcut; Lucy Z Kornblith; Carolyn Hendrickson; Elizabeth J Kovacs; Cara Joyce
Journal:  Ann Surg       Date:  2021-03-10       Impact factor: 13.787

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.